You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Neoatherosclerosis

Showing 1 - 18 of 18
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Patients With Restenosis of Calcified Lesions

Recruiting
  • Coronary Artery Calcification
  • +3 more
  • Coronary artery calcification lesions
  • Shenyang, Liaoning, China
    ShenyangNH
Jul 14, 2022

Neoatherosclerosis in ISR Patients Based on Artifical

Recruiting
  • In-stent Restenosis
  • +2 more
  • no interventin
  • Beijing, China
    The General Hospital of PLA
Jan 13, 2021

Lipid-Rich Atherosclerosis of Coronary Artery Trial in Miyazaki, Suita (near-infrared spectroscopy)

Recruiting
  • Lipid-Rich Atherosclerosis of Coronary Artery
  • near-infrared spectroscopy
  • Miyazaki, Japan
  • +1 more
Nov 23, 2022

Coronary Artery Disease Trial (DynamX Bioadaptor)

Not yet recruiting
  • Coronary Artery Disease
  • DynamX Bioadaptor
  • (no location specified)
Aug 2, 2022

Diabetes, Coronary Artery Disease, Acute Coronary Syndrome Trial in Mexico City (Abluminus Sirolimus Eluting Stent System

Recruiting
  • Diabetes Mellitus
  • +2 more
  • Abluminus Sirolimus Eluting Stent System (ASES)
  • Orsiro Sirolimus Eluting Coronary Stent System (OSES)
  • Mexico City, Tlalpan, Mexico
    Instituto Nacional de Cardiología Ignacio Chávez
Mar 8, 2022

Imaging-Guided Vessel Sizing in the Tibial Arteries

Recruiting
  • Peripheral Artery Disease
  • Critical Limb Ischemia
  • Digital Subtraction Angiography
  • Beachwood, Ohio
  • +2 more
Jul 6, 2022

In-stent Restenosis Trial in Belgium, France, Switzerland (Optical Coherence Tomography (OCT))

Recruiting
  • In-stent Restenosis
  • Optical Coherence Tomography (OCT)
  • Leuven, Belgium
  • +26 more
Feb 23, 2021

After Percutaneous Coronary Intervention With Stenting In

Recruiting
  • Coronary Artery Disease
  • Obstructive Sleep Apnea of Adult
  • OSA
  • Non-OSA
  • Beijing, China
    Beijing Anzhen Hospital, Capital Medical University
Sep 2, 2021

Coronary Artery Disease, Angina Pectoris Trial in Kobe (EPA and rosuvastatin, High dose rosuvastatin)

Unknown status
  • Coronary Artery Disease
  • Angina Pectoris
  • EPA and rosuvastatin
  • High dose rosuvastatin
  • Kobe, Hyogo, Japan
    Kobe University Graduate School of Medicine, Department of Cardi
Sep 16, 2018

Alirocumab for Neoatherosclerosis by Using OCT, in Comparison

Recruiting
  • Coronary Artery Disease Progression
  • Kobe, Hyogo, Japan
    Kobe University Graduate School of Medicine, Department of Cardi
May 28, 2018

Among HDL Functionality, Neoatherosclerosis and Target Lesion

Completed
  • Coronary Artery Disease Progression
  • neoatherosclerosis
  • Kobe, Hyogo, Japan
    Kobe University Graduate School of Medicine, Department of Cardi
May 28, 2018

Coronary Artery Disease Progression Trial (EPA and high dose rosuvastatin, Standard dose rosuvastatin)

Completed
  • Coronary Artery Disease Progression
  • EPA and high dose rosuvastatin
  • Standard dose rosuvastatin
  • (no location specified)
Jan 8, 2018

Stable Angina, Ischemic Heart Disease, Coronary Artery Disease Trial (Provisional DCB approach PCI procedure, Standard

Not yet recruiting
  • Stable Angina
  • +4 more
  • Provisional DCB approach PCI procedure
  • Standard provisional approach PCI procedure
  • (no location specified)
May 23, 2020

Macrophage Coronary Plaque by Optical Tomographic Imaging

Completed
  • Atherosclerotic Plaque
  • The heart subject will undergo OCT
  • Seoul, Songpa-Gu, Korea, Republic of
    Asan Medical Center
Sep 5, 2018

Coronary Artery Disease Trial in Jena (OCT-guided BRS implantation, FFR-guided DCB-only PCI)

Terminated
  • Coronary Artery Disease
  • OCT-guided BRS implantation
  • FFR-guided DCB-only PCI
  • Jena, Germany
    University Hospital of Jena, Heart Center, Division of Cardiolog
Oct 24, 2018

Coronary Artery Disease, Coronary Disease, Cardiovascular Diseases Trial in Seoul (Rosuvastatin 5mg, Rosuvastatin 20mg)

Unknown status
  • Coronary Artery Disease
  • +2 more
  • Rosuvastatin 5mg
  • Rosuvastatin 20mg
  • Seoul, Korea, Republic of
    Korea University Anam Hospital
Aug 4, 2016

Coronary Artery Lesions Trial in Bergamo (EES SYNERGY™, ZES, RESOLUTE Integrity™)

Unknown status
  • Coronary Artery Lesions
  • EES SYNERGY™
  • ZES, RESOLUTE Integrity™
  • Bergamo, Italy
    A.O. Ospedale Papa Giovanni XXIII
Jul 2, 2015

Angina, Unstable, Diabetes Trial in Beijing (Nicorandil, nicorandil )

Unknown status
  • Angina, Unstable
  • Diabetes Mellitus
  • Beijing, Beijing, China
    Chinese PLA General Hospital
Jan 17, 2015